Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009–2013)

[1]  W. Hamilton,et al.  Antimicrobial resistance: a major threat to public health , 2016 .

[2]  G. Bou,et al.  Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology? , 2013, The Journal of antimicrobial chemotherapy.

[3]  C. Hsiung,et al.  Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial Usage , 2012, PloS one.

[4]  T. Lisboa,et al.  Hand Hygiene, and Not Ertapenem Use, Contributed to Reduction of Carbapenem-Resistant Pseudomonas aeruginosa Rates , 2011, Infection Control & Hospital Epidemiology.

[5]  Lennart Sjöberg,et al.  Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis , 2011 .

[6]  A. C. O. Silveira,et al.  Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii in high complexity hospital. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[7]  A. Gales,et al.  Carbapenem-resistant Pseudomonas aeruginosa: clonal spread in southern Brazil and in the state of Goiás. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[8]  A. So,et al.  Tackling antibiotic resistance , 2010, BMJ : British Medical Journal.

[9]  Bala Hota,et al.  Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Daniel Yordanov,et al.  Pseudomonas aeruginosa - a phenomenon of bacterial resistance. , 2009, Journal of medical microbiology.

[11]  M. Antonelli,et al.  Antibiotic Usage and Risk of Colonization and Infection with Antibiotic-Resistant Bacteria: a Hospital Population-Based Study , 2009, Antimicrobial Agents and Chemotherapy.

[12]  Á. Soriano,et al.  Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients , 2009, Intensive Care Medicine.

[13]  A. Messadi,et al.  Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004. , 2008, Burns : journal of the International Society for Burn Injuries.

[14]  Emmanuel Roilides,et al.  Differential Correlation Between Rates of Antimicrobial Drug Consumption and Prevalence of Antimicrobial Resistance in a Tertiary Care Hospital in Greece , 2008, Infection Control & Hospital Epidemiology.

[15]  O. Cars,et al.  Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. , 2008, The Lancet. Infectious diseases.

[16]  C. Butler,et al.  The role of evidence in the decline of antibiotic use for common respiratory infections in primary care. , 2007, The Lancet. Infectious diseases.

[17]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  P. Lebecque,et al.  Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  L. Rice.  Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Akçay,et al.  The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit. , 2005, Burns : journal of the International Society for Burn Injuries.

[21]  M. Nucci,et al.  Risk Factors for Acquisition of Multidrug-Resistant Pseudomonas aeruginosa Producing SPM Metallo-β-Lactamase , 2005, Antimicrobial Agents and Chemotherapy.

[22]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[23]  E. Tacconelli,et al.  Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. , 2004, The Journal of antimicrobial chemotherapy.

[24]  Ronald N. Jones,et al.  Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001). , 2004, The Journal of antimicrobial chemotherapy.

[25]  D. Livermore.  Can better prescribing turn the tide of resistance? , 2004, Nature Reviews Microbiology.

[26]  J. Högel,et al.  Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa , 2002, Antimicrobial Agents and Chemotherapy.

[27]  M. Lipsitch,et al.  Antimicrobial Use and Antimicrobial Resistance: A Population Perspective , 2002, Emerging Infectious Diseases.

[28]  Y. Carmeli,et al.  Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  F. Bager.  DANMAP: monitoring antimicrobial resistance in Denmark. , 2000, International journal of antimicrobial agents.

[30]  R. Gaynes,et al.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  O. Cars,et al.  Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). , 1999, Scandinavian journal of infectious diseases.